Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan;54(1):45-63.
doi: 10.4132/jptm.2019.11.05. Epub 2020 Jan 15.

Molecular characteristics of meningiomas

Young Suk Lee  1 , Youn Soo Lee  1
Affiliations
Review

Molecular characteristics of meningiomas

Young Suk Lee et al. J Pathol Transl Med. 2020 Jan.

Abstract

Meningioma is the most common primary intracranial tumor in adults. The grading of meningioma is based on World Health Organization criteria, which rely on histopathological features alone. This grading system is unable to conclusively predict the clinical behavior of these tumors (i.e., recurrence or prognosis in benign or atypical grades). Advances in molecular techniques over the last decade that include genomic and epigenomic data associated with meningiomas have been used to identify genetic biomarkers that can predict tumor behavior. This review summarizes the molecular characteristics of meningioma using genetic and epigenetic biomarkers. Molecular alterations that can predict meningioma behavior may be integrated into the upcoming World Health Organization grading system.

Keywords: Meningioma; Molecular diagnosis; Pathological diagnosis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

The authors declare that they have no potential conflicts of interest.

Figures

Fig. 1.
Fig. 1.
Overview of the 2016 World Health Organization classification system for grading meningiomas. HPF, high-power fields; N/C, nuclear/cytoplasmic.
Fig. 2.
Fig. 2.
The most common genetic alterations found in meningiomas.
Fig. 3.
Fig. 3.
Cytogenetic changes during initiation and progression of meningiomas.
Fig. 4.
Fig. 4.
Molecular signaling pathways associated with meningiomas.
See this image and copyright information in PMC

References

    1. Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol. 2010;99:307–14. - PMC - PubMed
    1. Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015. Neuro Oncol. 2018;20:iv1–86. - PMC - PubMed
    1. Tufan K, Dogulu F, Kurt G, Emmez H, Ceviker N, Baykaner MK. Intracranial meningiomas of childhood and adolescence. Pediatr Neurosurg. 2005;41:1–7. - PubMed
    1. Kotecha RS, Pascoe EM, Rushing EJ, et al. Meningiomas in children and adolescents: a meta-analysis of individual patient data. Lancet Oncol. 2011;12:1229–39. - PubMed
    1. Kalamarides M, Stemmer-Rachamimov AO, Niwa-Kawakita M, et al. Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes. Oncogene. 2011;30:2333–44. - PubMed

LinkOut - more resources